Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (355)

« Back to Publications

Seeing something new or with new eyes?

Hills RK., (2025), Br J Haematol, 207, 2231 - 2232

Treatment Intensification With Either Fludarabine, AraC, G-CSF and Idarubicin, or Cladribine Plus Daunorubicin and AraC on the Basis of Residual Disease Status in Older Patients With AML: Results From the NCRI AML18 Trial.

Russell NH. et al, (2025), J Clin Oncol, 43, 694 - 704

Review of the target trial methodological approach on treatment effect estimates in kidney failure: protocol for a systematic assessment.

Pinter J. et al, (2024), Syst Rev, 13

Evaluation of CD3 and CD8 T-Cell Immunohistochemistry for Prognostication and Prediction of Benefit From Adjuvant Chemotherapy in Early-Stage Colorectal Cancer Within the QUASAR Trial.

Williams CJM. et al, (2024), J Clin Oncol, 42, 3430 - 3442

Genomic characterization of AML with aberrations of chromosome 7: a multinational cohort of 519 patients.

Halik A. et al, (2024), J Hematol Oncol, 17

Benefits and risks of anthracyclines in early-stage breast cancer - Authors' reply.

Braybrooke J. et al, (2024), Lancet, 403

andomised evaluation of low-dose cytosine arabinoside plus lenalidomide versus single-agent low-dose cytosine arabinoside in older patients with acute myeloid leukaemia: Results from the LI-1 trial.

Copland M. et al, (2024), Br J Haematol, 204, 871 - 876

Prognostic impact of CEBPA mutational subgroups in adult AML.

Georgi J-A. et al, (2024), Leukemia, 38, 281 - 290

The Use of the Target Trial Approach in Kidney Disease: A Methodological Systematic Review Protocol

Pinter J. et al, (2024)

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials.

Early Breast Cancer Trialists' Collaborative Group (EBCTCG) ., (2023), Lancet, 402, 1991 - 2003

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial.

Freeman SD. et al, (2023), Blood, 142, 1697 - 1707

cute myeloid leukaemia in Afghanistan: Understanding an unfamiliar landscape.

Hills RK., (2023), Br J Haematol, 203, 353 - 354

Factors Predicting Long-term Outcome and the Need for Surgery in Graves Orbitopathy: Extended Follow-up From the CIRTED Trial.

Taylor P. et al, (2023), J Clin Endocrinol Metab, 108, 2615 - 2625

What drives CAR-T emergent cytopenia?

Hills RK., (2023), Br J Haematol, 202, 213 - 214

nthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials.

Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Electronic address: bc.overview@ctsu.ox.ac.uk . and Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) ., (2023), Lancet, 401, 1277 - 1292

Load More

1
2
3
4
5
6
7
...
»